SUBSCRIPTION AGREEMENT FOR PROSPECTIVE SUBSCRIBERS OF UNITS SANGUINE CORPORATIONSubscription Agreement • September 15th, 2000 • Sanguine Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 15th, 2000 Company Industry
DAVID E. NELSON 528 East 14th Avenue SALT LAKE CITY, UTAH 84103 SANGUINE CORPORATION LOCKUP AGREEMENT Date: June 2, 2000 Sanguine Corporation 101 Green Street, Suite 11 Pasadena, CA 91105 Dear Dr. Drees, The undersigned understands that Sanguine...Sanguine Corp • September 15th, 2000 • In vitro & in vivo diagnostic substances
Company FiledSeptember 15th, 2000 IndustryThe undersigned understands that Sanguine Corporation, a Nevada Corporation (the "Company") intends to conduct a private offering of its Common Stock through Laidlaw Global Securities, Inc. ("Laidlaw"). The undersigned recognizes the benefits which the Company will derive from the offering. For and in consideration of the Company's willingness to register the shares of Common Stock, and other consideration, the undersigned hereby agrees as follows:
SANGUINE CORPORATION Up to 10,000,000 Units, Each Unit Consisting of Two Shares of Common Stock and One Redeemable Common Stock Purchase Warrant PLACEMENT AGENCY AGREEMENT May 18, 2000 Laidlaw Global Securities, Inc. 100 Park Avenue New York, New York...Sanguine Corporation • September 15th, 2000 • Sanguine Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 15th, 2000 Company Industry Jurisdiction
SCS, Inc. letterhead] SANGUINE CORPORATION LOCKUP AGREEMENT Date: June 2, 2000 Sanguine Corporation 101 Green Street, Suite 11 Pasadena, CA 91105 Dear Dr. Drees, The undersigned understands that Sanguine Corporation, a Nevada Corporation (the...Corporation Lockup Agreement • September 15th, 2000 • Sanguine Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 15th, 2000 Company IndustryThe undersigned understands that Sanguine Corporation, a Nevada Corporation (the "Company") intends to conduct a private offering of its Common Stock through Laidlaw Global Securities, Inc. ("Laidlaw"). The undersigned recognizes the benefits which the Company will derive from the offering. For and in consideration of the Company's willingness to register the shares of Common Stock, and other consideration, the undersigned hereby agrees as follows:
LEONARD W. BURNINGHAM 455 EAST 500 SOUTH, SUITE #205 SALT LAKE CITY, UTAH 84111 SANGUINE CORPORATION LOCKUP AGREEMENT Date: June 2, 2000 Sanguine Corporation 101 Green Street, Suite 11 Pasadena, CA 91105 Dear Dr. Drees, The undersigned understands...Sanguine Corp • September 15th, 2000 • In vitro & in vivo diagnostic substances
Company FiledSeptember 15th, 2000 IndustryThe undersigned understands that Sanguine Corporation, a Nevada Corporation (the "Company") intends to conduct a private offering of its Common Stock through Laidlaw Global Securities, Inc. ("Laidlaw"). The undersigned recognizes the benefits which the Company will derive from the offering. For and in consideration of the Company's willingness to register the shares of Common Stock, and other consideration, the undersigned hereby agrees as follows:
LAIDLAW GLOBAL SECURITIES, INC. AND SANGUINE CORPORATION PLACEMENT AGENT'S UNIT PURCHASE WARRANT AGREEMENT Dated as of August 29, 2000 PLACEMENT AGENT'S UNIT PURCHASE WARRANT AGREEMENT dated as of August 29, 2000 between LAIDLAW GLOBAL SECURITIES,...Purchase Warrant Agreement • September 15th, 2000 • Sanguine Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 15th, 2000 Company Industry Jurisdiction